91桃色

ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

GeneXpert: A new tool for the rapid detection of Rifampicin resistance in Mycobacterium tuberculosis

International Conference on Infectious Diseases, Diagnostic Microbiology & Dermatologists Summit on Skin Infections

Muhammad Saeed

Allama Iqbal Medical College, Pakistan

ScientificTracks Abstracts: J Infect Dis Ther

DOI:

Abstract
To evaluate the diagnostic sensitivity and specificity of GeneXpert (MTB/RIF) assay for the detection of rifampicin (RIF) resistance in Mycobacterium tuberculosis (MTB) by comparing the results with conventional drug susceptibility testing (DST) as 芒??Gold Standard芒?聺. A total of 2200 pulmonary and extra-pulmonary specimens were collected from TB suspects from 2012 to 2014. All specimens were processed for ZN staining, LJ culture according to WHO protocol GeneXpert (MTB/RIF) as per manufacturer instructions. All cases positive for MTB were further processed for DST for RIF. Out of 2200 Tb suspects, 840 (38.18%) cases were GeneXpert (MTB/RIF) positive for MTB. Among these 15.6% (134/840) cases showed RIF resistance. The sensitivity, specificity, PPV and NPV of GeneXpert for RIF resistance were found to be 98.3%. 99.1%, 94.7% and 99.4% respectively by comparing the results with DST. Our study revealed that GeneXpert (MTB/RIF) is an extremely helpful diagnostic tool for detection of RIF resistance in TB suspects with fairly high sensitivity and specificity along with 2 hours turnout time, which facilitates proper in time management and treatment among MDR-TB patients in developing countries.
Biography

Muhammad Saeed has completed his BSc in Medical Laboratory Technology from University of Health Sciences Lahore, Pakistan. He is working as a Medical Laboratory Technologist in Punjab Institute of Cardiology Lahore. He has published more than 9 research papers in well reputed Pakistani journal.

Email: twanagol@yahoo.com

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top